Amantadine as adjuvant therapy in the treatment of moderate to severe OCD: a double blind randomized trial with placebo control
ConclusionThe results of this study suggest that amantadine may be effective as an augmentative agent in the treatment of moderate ‐to‐severe OCD.This article is protected by copyright. All rights reserved.
Source: Psychiatry and Clinical Neurosciences - Category: Neuroscience Authors: Sina Naderi,
Heidar Faghih,
Ali Aqamolaei,
Seyyed Hosein Mortazavi,
Amirhosein Mortezaei,
Erfan Sahebolzamani,
Farzin Rezaei,
Shahin Akhondzadeh Tags: Regular Article Source Type: research
More News: Amantadine | Brain | Neurology | Neuroscience | Obsessive Compulsive Disorder | Psychiatry | Study | Symmetrel | Yale